Biotech Lock-Up Expiration Hell Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (997)	12/3/2004 3:40:19 PM
From: tuck	Read Replies (1) of 1005

Nice call! Wasn't it a SynX patent grant that started the run? NGEN seems to be getting some good immediate mileage from that munch. Still think it's near term prospects suck on a fundamental basis. Was this a quick technical trade on your part, or a position trade? Would like to hear your rationale if the latter. Let me know when you sell if it's the former. A couple of other moribund BLUE HP stocks are reviving. ARNA's off its lows on making some clinical progress, and CALP seems to be turning around. Others, like LSBC, ICOR, and AGNT seem to have little hope of achieving that. I'm guessing ICOR has the best chance of those three. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next